Intranasal immunization with recombinant chlamydial protease-like activity factor attenuates atherosclerotic pathology following Chlamydia pneumoniae infection in mice

We have shown previously that intranasal vaccination with recombinant chlamydial protease-like activity factor (rCPAF: antigen) and interleukin-12 (IL-12) as an adjuvant induces robust protection against pathological consequences of female genital tract infection with Chlamydia muridarum, a closely...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Immunol Cell Biol
Päätekijät: Li, Weidang, Gudipaty, Pareesha, Li, Chuxi, Henderson, Kyle K., Ramsey, Kyle H., Murthy, Ashlesh K.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2018
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6338504/
https://ncbi.nlm.nih.gov/pubmed/30051926
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/imcb.12192
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia